PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY COMPRISING SPHINGOSINE-1-PHOSPHATE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS AN ACTIVE INGREDIENT

摘要

The present invention relates to a pharmaceutical composition for preventing or treating obesity comprising sphingosine-1-phosphate or a pharmaceutically acceptable salt thereof as an active ingredient. The composition suppresses the expression of regulating factors associated with adipocyte differentiation via sphingosine-1-phosphate 2 receptors, such that it is efficacious in markedly inhibiting differentiation of adipocytes and suppressing the accumulation of lipids, and thus the composition can advantageously be used as an effective medicinal product for preventing or treating obesity.